Development of GZ38-1, a novel protectant of chemotherapy-induced myelosuppressio
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA174074
- Recipient
-
G1 Therapeutics, Inc. UEI L72RA25Z7LK3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,147,510
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Chapel Hill, NC 27599, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $11,565 | |
| Amendment | $522,431 | |
| Amendment | $462,399 | |
| Original award | $151,115 |
Quick answers
Who received award R44CA174074?
R44CA174074 was awarded to G1 Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on May 16, 2013.
How much is award R44CA174074 worth?
$1,147,510 has been obligated on R44CA174074.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award